Standards Comparison

    FDA 21 CFR Part 11

    Mandatory
    1997

    FDA regulation for trustworthy electronic records and signatures

    VS

    APRA CPS 234

    Mandatory
    2019

    Australian prudential standard for information security resilience

    Quick Verdict

    FDA 21 CFR Part 11 ensures electronic records/signatures trust for US life sciences, while APRA CPS 234 mandates cyber resilience for Australian finance. Pharma adopts Part 11 for FDA compliance; banks use CPS 234 to meet prudential oversight and avoid penalties.

    Electronic Records

    FDA 21 CFR Part 11

    21 CFR Part 11: Electronic Records; Electronic Signatures

    Cost
    €€€€
    Complexity
    Medium
    Implementation Time
    18-24 months

    Key Features

    • Establishes equivalence of electronic records to paper
    • Mandates secure, time-stamped audit trails
    • Requires unique, non-repudiable electronic signatures
    • Enforces closed/open system access controls
    • Demands risk-based system validation
    Information Security

    APRA CPS 234

    APRA Prudential Standard CPS 234 Information Security

    Cost
    €€€€
    Complexity
    High
    Implementation Time
    12-18 months

    Key Features

    • Board ultimate responsibility for information security
    • 72-hour APRA notification for material incidents
    • Third-party asset management requirements
    • Systematic independent control testing program
    • Asset classification by criticality and sensitivity

    Detailed Analysis

    A comprehensive look at the specific requirements, scope, and impact of each standard.

    FDA 21 CFR Part 11 Details

    What It Is

    FDA 21 CFR Part 11 is a U.S. regulation establishing criteria for electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It applies to FDA-regulated industries using electronic systems for predicate-rule records. The risk-based approach narrows scope to relied-upon electronic records, with enforcement discretion on some elements like validation.

    Key Components

    • **Subpart AScope, definitions (closed/open systems).
    • **Subpart BControls for records (audit trails, access, validation; §11.10/11.30).
    • **Subpart CSignature requirements (uniqueness, linking, multi-component; §§11.50-11.300). Core principles include data integrity (ALCOA+), non-repudiation. No formal certification; compliance via inspection.

    Why Organizations Use It

    Ensures regulatory acceptance of digital records, mitigates enforcement risks (warnings, holds), supports data integrity for quality decisions. Benefits: efficiency, inspection readiness, stakeholder trust in pharma/biotech/devices.

    Implementation Overview

    Risk-based CSV (GAMP5): scope records, validate systems (IQ/OQ/PQ), implement controls, train users. Applies to life sciences; phased (6-24 months), ongoing via change control, audits.

    APRA CPS 234 Details

    What It Is

    APRA Prudential Standard CPS 234 (Information Security) is a binding regulation issued by the Australian Prudential Regulation Authority for regulated financial entities. Effective from 1 July 2019, it mandates maintaining information security capabilities commensurate with threats to ensure resilience against incidents impacting confidentiality, integrity, or availability (CIA) of information assets, including those managed by third parties.

    Key Components

    • **Governance and accountabilityBoard ultimate responsibility, defined roles.
    • **Risk managementAsset classification by criticality/sensitivity, commensurate controls.
    • **Testing and assuranceSystematic testing, internal audit reviews.
    • **Incident response72-hour APRA notification for material incidents, annual plan testing. Built on risk-based, assurance-driven principles; no fixed control count, focuses on outcomes.

    Why Organizations Use It

    Mandatory for APRA-regulated entities (banks, insurers, super funds); reduces cyber risks, ensures operational continuity, builds stakeholder trust. Enhances prudential compliance, avoids penalties, strengthens third-party oversight.

    Implementation Overview

    Phased approach: gap analysis, policy framework, asset inventory, controls/testing, third-party assessments. Applies to all sizes in Australian financial sector; requires ongoing assurance, no formal certification but APRA supervision.

    Key Differences

    Scope

    FDA 21 CFR Part 11
    Electronic records/signatures equivalence to paper
    APRA CPS 234
    Information security capability and cyber resilience

    Industry

    FDA 21 CFR Part 11
    US life sciences, pharma, medical devices
    APRA CPS 234
    Australian financial services (banks, insurers)

    Nature

    FDA 21 CFR Part 11
    Mandatory US FDA regulation with enforcement discretion
    APRA CPS 234
    Mandatory prudential standard with strict notifications

    Testing

    FDA 21 CFR Part 11
    Risk-based system validation, audit trails
    APRA CPS 234
    Systematic independent control testing annually

    Penalties

    FDA 21 CFR Part 11
    Warning letters, product holds, enforcement actions
    APRA CPS 234
    Supervisory directions, penalties, license restrictions

    Frequently Asked Questions

    Common questions about FDA 21 CFR Part 11 and APRA CPS 234

    FDA 21 CFR Part 11 FAQ

    APRA CPS 234 FAQ

    You Might also be Interested in These Articles...

    Run Maturity Assessments with GRADUM

    Transform your compliance journey with our AI-powered assessment platform

    Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

    100+ Standards & Regulations
    AI-Powered Insights
    Collaborative Assessments
    Actionable Recommendations

    Check out these other Gradum.io Standards Comparison Pages